As COVID-19 continues to change the clinical trial landscape, innovations in site and patient engagements will help determine the success of oncology trials.
Join us for our upcoming webinar with Dr. Ari VanderWalde, a member of George Clinical’s scientific leadership team with oncology clinical research expertise, May 27th.
This webcast will give the oncology community an in-depth understanding of preparing safe and efficient trials and implementing best practices to mitigate disruption during COVID-19 restrictions.
Topics covered in this webinar include:
The session will be streamed live on: May 27, 11:00 am USA CDT
Dr. VanderWalde specializes in melanoma and is experienced in genomic tumor assessment, public health, tumor immunotherapy, medical ethics and precision oncology. He is the Global Head of Clinical Research at Caris Life Sciences and works as Research Faculty at West Cancer Center where he served as the Director of Research from 2014 to 2021. He is also Professor in the Division of Epidemiology at the University of Memphis School of Public Health. Dr. VanderWalde has extensive experience in clinical research, including the design and conduct of clinical trials, results reporting, regulatory filing and interactions between investigators and the pharmaceutical industry.
Meet with George Clinical! Contact us to schedule a time now.